{"url":"https://lda.senate.gov/api/v1/filings/6f4e13cf-e663-4be4-bb33-49551dbde883/","filing_uuid":"6f4e13cf-e663-4be4-bb33-49551dbde883","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/6f4e13cf-e663-4be4-bb33-49551dbde883/print/","filing_document_content_type":"text/html","income":null,"expenses":"460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"James Fenton, Executive Director, Government Affairs","dt_posted":"2025-01-21T18:23:04-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1851 Harbor Bay Parkway","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alameda","registrant_state":"CA","registrant_zip":"94502","registrant":{"id":401105195,"url":"https://lda.senate.gov/api/v1/registrants/401105195/","house_registrant_id":null,"name":"EXELIXIS INC.","description":"Genomics-based drug discovery company","address_1":"1851 Harbor Bay Parkway","address_2":null,"address_3":null,"address_4":null,"city":"Alameda","state":"CA","state_display":"California","zip":"94502","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES FENTON","contact_telephone":"+1 202-536-7683","dt_updated":"2026-07-29T12:33:27.514122-04:00"},"client":{"id":203381,"url":"https://lda.senate.gov/api/v1/clients/203381/","client_id":12,"name":"EXELIXIS INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.5028, The Small Business Biotech Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71343,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"M.","last_name":"FENTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118865,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"HERMANCE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139401,"prefix":"mr","prefix_display":"MR.","first_name":"JARED","nickname":null,"middle_name":"DANIEL","last_name":"MICHAUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"IRC Section 174 amortization of R&D expenditures","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71343,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":"M.","last_name":"FENTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":118865,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"HERMANCE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139401,"prefix":"mr","prefix_display":"MR.","first_name":"JARED","nickname":null,"middle_name":"DANIEL","last_name":"MICHAUD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}